TargetSodium-dependent dopamine transporter(Rattus norvegicus (rat))
University Of Montpellier
Curated by ChEMBL
University Of Montpellier
Curated by ChEMBL
Affinity DataIC50: 1.75nMAssay Description:Inhibitory activity of compound against [3H]-BTCP binding to neuronal dopamine transporter of rat striatal membraneMore data for this Ligand-Target Pair
TargetSodium-dependent dopamine transporter(Rattus norvegicus (rat))
University Of Montpellier
Curated by ChEMBL
University Of Montpellier
Curated by ChEMBL
Affinity DataIC50: 8.40nMAssay Description:Inhibitory activity of compound against [3H]-BTCP binding to neuronal dopamine transporter of rat striatal membraneMore data for this Ligand-Target Pair
TargetSodium-dependent dopamine transporter(Rattus norvegicus (rat))
University Of Montpellier
Curated by ChEMBL
University Of Montpellier
Curated by ChEMBL
Affinity DataIC50: 15.9nMAssay Description:Inhibitory activity of compound against [3H]-BTCP binding to neuronal dopamine transporter of rat striatal membraneMore data for this Ligand-Target Pair
TargetSodium-dependent dopamine transporter(Rattus norvegicus (rat))
University Of Montpellier
Curated by ChEMBL
University Of Montpellier
Curated by ChEMBL
Affinity DataIC50: 53.4nMAssay Description:Inhibitory activity of compound against [3H]-BTCP binding to neuronal dopamine transporter of rat striatal membraneMore data for this Ligand-Target Pair
TargetSodium-dependent dopamine transporter(Rattus norvegicus (rat))
University Of Montpellier
Curated by ChEMBL
University Of Montpellier
Curated by ChEMBL
Affinity DataIC50: 113nMAssay Description:Inhibitory activity of compound against [3H]-BTCP binding to neuronal dopamine transporter of rat striatal membraneMore data for this Ligand-Target Pair
Affinity DataIC50: 8.20E+3nMAssay Description:Antagonist activity at human TLR7 expressed in HEK-blue cells assessed as inhibition of CL264-induced NFkappaB activation after 24 hrs using qunati-b...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+4nMAssay Description:Antagonist activity at human TLR7 expressed in HEK-blue cells assessed as inhibition of CL264-induced NFkappaB activation after 24 hrs using qunati-b...More data for this Ligand-Target Pair
Affinity DataIC50: 1.63E+4nMAssay Description:Antagonist activity at human TLR7 expressed in HEK-blue cells assessed as inhibition of CL264-induced NFkappaB activation after 24 hrs using qunati-b...More data for this Ligand-Target Pair
Affinity DataIC50: 1.73E+4nMAssay Description:Antagonist activity at human TLR7 expressed in HEK-blue cells assessed as inhibition of CL264-induced NFkappaB activation after 24 hrs using qunati-b...More data for this Ligand-Target Pair
Affinity DataIC50: 1.77E+4nMAssay Description:Antagonist activity at human TLR7 expressed in HEK-blue cells assessed as inhibition of CL264-induced NFkappaB activation after 24 hrs using qunati-b...More data for this Ligand-Target Pair
Affinity DataIC50: 2.20E+4nMAssay Description:Antagonist activity at human TLR7 expressed in HEK-blue cells assessed as inhibition of CL264-induced NFkappaB activation after 24 hrs using qunati-b...More data for this Ligand-Target Pair
Affinity DataIC50: 2.35E+4nMAssay Description:Antagonist activity at human TLR7 expressed in HEK-blue cells assessed as inhibition of CL264-induced NFkappaB activation after 24 hrs using qunati-b...More data for this Ligand-Target Pair
Affinity DataIC50: 2.36E+4nMAssay Description:Antagonist activity at human TLR7 expressed in HEK-blue cells assessed as inhibition of CL264-induced NFkappaB activation after 24 hrs using qunati-b...More data for this Ligand-Target Pair
Affinity DataIC50: 2.60E+4nMAssay Description:Antagonist activity at human TLR7 expressed in HEK-blue cells assessed as inhibition of CL264-induced NFkappaB activation after 24 hrs using qunati-b...More data for this Ligand-Target Pair
Affinity DataIC50: 3.06E+4nMAssay Description:Antagonist activity at human TLR7 expressed in HEK-blue cells assessed as inhibition of CL264-induced NFkappaB activation after 24 hrs using qunati-b...More data for this Ligand-Target Pair
Affinity DataIC50: 3.25E+4nMAssay Description:Antagonist activity at human TLR7 expressed in HEK-blue cells assessed as inhibition of CL264-induced NFkappaB activation after 24 hrs using qunati-b...More data for this Ligand-Target Pair
Affinity DataIC50: 3.90E+4nMAssay Description:Antagonist activity at human TLR7 expressed in HEK-blue cells assessed as inhibition of CL264-induced NFkappaB activation after 24 hrs using qunati-b...More data for this Ligand-Target Pair
Affinity DataIC50: 4.00E+4nMAssay Description:Antagonist activity at human TLR7 expressed in HEK-blue cells assessed as inhibition of CL264-induced NFkappaB activation after 24 hrs using qunati-b...More data for this Ligand-Target Pair
Affinity DataIC50: 4.25E+4nMAssay Description:Antagonist activity at human TLR7 expressed in HEK-blue cells assessed as inhibition of CL264-induced NFkappaB activation after 24 hrs using qunati-b...More data for this Ligand-Target Pair
Affinity DataIC50: 4.25E+4nMAssay Description:Antagonist activity at human TLR7 expressed in HEK-blue cells assessed as inhibition of CL264-induced NFkappaB activation after 24 hrs using qunati-b...More data for this Ligand-Target Pair
Affinity DataIC50: 4.50E+4nMAssay Description:Antagonist activity at human TLR7 expressed in HEK-blue cells assessed as inhibition of CL264-induced NFkappaB activation after 24 hrs using qunati-b...More data for this Ligand-Target Pair
Affinity DataIC50: 4.85E+4nMAssay Description:Antagonist activity at human TLR7 expressed in HEK-blue cells assessed as inhibition of CL264-induced NFkappaB activation after 24 hrs using qunati-b...More data for this Ligand-Target Pair
Affinity DataIC50: 4.95E+4nMAssay Description:Antagonist activity at human TLR7 expressed in HEK-blue cells assessed as inhibition of CL264-induced NFkappaB activation after 24 hrs using qunati-b...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+4nMAssay Description:Antagonist activity at human TLR7 expressed in HEK-blue cells assessed as inhibition of CL264-induced NFkappaB activation after 24 hrs using qunati-b...More data for this Ligand-Target Pair
Affinity DataIC50: 8.40E+4nMAssay Description:Antagonist activity at human TLR7 expressed in HEK-blue cells assessed as inhibition of CL264-induced NFkappaB activation after 24 hrs using qunati-b...More data for this Ligand-Target Pair